SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells

Anticancer Res. 2008 Sep-Oct;28(5A):2733-5.

Abstract

Background: Keratinocyte growth factor (KGF) produces a rapid increase in the proliferation and motility of estrogen receptor (ER)-positive breast cancer cells which is abolished by estrogen deprivation and/or anti-estrogen treatment. The present study examined the hypothesis that ER-alpha is involved in the KGF proliferation in MCF-7 cancer cells using small interfering RNA (siRNA) to selectively inhibit ER-alpha expression.

Materials and methods: At 48 hours following ER-alpha siRNA transfection, the MCF-7 cells were treated with KGF (50 ng/ml) or vehicle for 24 hours. Cell proliferation was measured using a MTT assay. ER-alpha protein levels were quantified by Western blotting.

Results: ER-alpha siRNA transfection significantly reduced ER-alpha expression and MCF-7 cell proliferation. KGF-mediated enhancement of cell proliferation and motile cell morphology were reduced or absent in the siRNA transfected MCF-7 cells.

Conclusion: ER-alpha expression is associated with KGF-induced proliferation of breast cancer cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Cell Growth Processes / drug effects
  • Cell Growth Processes / genetics
  • Cell Line, Tumor
  • Estrogen Receptor alpha / antagonists & inhibitors*
  • Estrogen Receptor alpha / biosynthesis
  • Estrogen Receptor alpha / genetics
  • Fibroblast Growth Factor 7 / antagonists & inhibitors
  • Fibroblast Growth Factor 7 / pharmacology*
  • Humans
  • RNA, Small Interfering / genetics*
  • Transfection

Substances

  • Estrogen Receptor alpha
  • RNA, Small Interfering
  • Fibroblast Growth Factor 7